Role of Transcutaneous CO2 Monitoring in High-Risk Respiratory Patients
Can't see this email? View it online
   
  August 13, 2018  
  Respiratory Diseases  
  The latest respiratory diseases news from News Medical  
 

#ALT# Webinar: Role of Transcutaneous CO2 Monitoring in High-Risk Respiratory Patients

All clinicians understand that disasters are more likely to be averted when trends are detected early. Thanks to purely non-invasive transcutaneous CO2 measurement (TcCO2), serious respiratory events can be predicted more dependably than ever before.

Read Full Article Here
 
   Study shows COPD risk in women with asthma can be reducedStudy shows COPD risk in women with asthma can be reduced
 
A new study shows that there is a high chance of chronic obstructive pulmonary disease (COPD) in women who have asthma, but also that this risk can be reduced by appropriate intervention.
 
   JRC's new report identifies lung cancer trends in EuropeJRC's new report identifies lung cancer trends in Europe
 
Scientists at the Joint Research Centre, the European Commission's Science and Knowledge service, place Europe's regions under the microscope in a report identifying cancer trends within and across countries.
 
 Study provides new insights into how asthma develops and progresses
 
Study provides new insights into how asthma develops and progressesOf the more than 24 million people in the U.S. who have asthma, 10 percent have severe asthma - a form of the disease that does not respond to treatment.
 
 
 Discovery of new epithelial lung cell type may affect cystic fibrosis therapy
 
Discovery of new epithelial lung cell type may affect cystic fibrosis therapyScientists have discovered a new type of cell in the human respiratory tract called the pulmonary ionocyte, and linked it to cystic fibrosis. Pulomonary ionocytes make up about one percent of the cells in the lung and are thought to be responsible for cystic fibrosis, the incurable multiorgan disease which affects more than 70 000 people around the world.
 
 
 Blood-based test accurately identifies lung cancer patients who could benefit from immunotherapies
 
Blood-based test accurately identifies lung cancer patients who could benefit from immunotherapiesResearchers at UC Davis, Genentech and Foundation Medicine are the first to show that a blood-based test to assess tumor mutational burden accurately identifies non-small cell lung cancer (NSCLC) patients who could benefit from immunotherapies called checkpoint inhibitors.
 
 
 Inhibition of NOVA1 gene helps prevent growth of lung cancer tumors
 
Inhibition of NOVA1 gene helps prevent growth of lung cancer tumorsResearchers have identified a gene that when inhibited or reduced, in turn, reduced or prevented human non-small cell lung cancer tumors from growing.
 
 
 Lung Cancer Screening Procedure
 
Lung Cancer Screening ProcedureLung cancer represents the leading cause of death from malignancies in men and women around the world. The seriousness of the problem is reflected in the number of people who succumb to lung cancer each year, which has risen sharply in the last 25 years and exceeded the number of deaths from breast, colorectal and prostate cancer combined.
 
 
 Lung Cancer and Electrolyte Imbalances
 
Lung Cancer and Electrolyte ImbalancesPatients with malignant diseases often experience imbalances in serum electrolytes, which include hyponatremia, hypokalemia/hyperkalemia, hypercalcemia and hypophosphatemia.